DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,298 filers reported holding DANAHER CORPORATION in Q4 2018. The put-call ratio across all filers is 1.15 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,369,447 | +125.0% | 20,230 | +118.9% | 0.52% | +80.2% |
| Q3 2022 | $2,386,000 | -2.5% | 9,240 | -4.3% | 0.29% | +3.6% |
| Q2 2022 | $2,447,000 | -9.2% | 9,656 | +5.1% | 0.28% | +3.7% |
| Q1 2022 | $2,694,000 | -56.1% | 9,185 | -50.7% | 0.27% | -52.8% |
| Q4 2021 | $6,132,000 | -5.6% | 18,638 | -12.6% | 0.57% | -9.4% |
| Q3 2021 | $6,495,000 | +6.3% | 21,336 | -6.3% | 0.63% | +10.2% |
| Q2 2021 | $6,111,000 | +146.4% | 22,775 | +106.7% | 0.57% | +128.5% |
| Q1 2021 | $2,480,000 | +25.9% | 11,020 | +24.2% | 0.25% | +22.1% |
| Q4 2020 | $1,970,000 | -7.1% | 8,872 | -9.9% | 0.20% | -11.3% |
| Q3 2020 | $2,121,000 | +23.2% | 9,851 | +1.2% | 0.23% | +17.9% |
| Q2 2020 | $1,721,000 | +57.5% | 9,734 | +30.2% | 0.20% | +29.1% |
| Q1 2020 | $1,093,000 | +20.4% | 7,476 | +26.4% | 0.15% | +58.9% |
| Q4 2019 | $908,000 | +0.8% | 5,916 | -5.2% | 0.10% | +1.1% |
| Q3 2019 | $901,000 | -7.1% | 6,241 | -8.0% | 0.09% | -6.9% |
| Q2 2019 | $970,000 | +46.1% | 6,786 | +34.9% | 0.10% | +60.3% |
| Q1 2019 | $664,000 | +27.9% | 5,031 | 0.0% | 0.06% | -12.5% |
| Q4 2018 | $519,000 | – | 5,031 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |